Patent ID: 8785605

Claim:
An isolated target binding member that binds IL-25, wherein the target binding comprises an antibody light chain variable region (VL) domain comprising a CDR1 having the amino acid sequence SASQGISNYLN (SEQ ID NO:6) and a CDR2 having the amino acid sequence YTSSLHS (SEQ ID NO:7) and a CDR3 having the amino acid sequence QQYLAFPYTF (SEQ ID NO:8) and an antibody heavy chain variable region (VH) domain comprising a CDR1 having the amino acid sequence GYTMN (SEQ ID NO:10), a CDR2having the amino acid sequence LINPYNGGTSYNQNFKG (SEQ ID NO:11) and a CDR3 having the amino acid sequence EDYDGYLYFAMDY (SEQ ID NO:12).